QuVa Pharma, a sterile compounding pharmaceutical company, recently acquired a new biotech facility in New Jersey.
The 160,000 square-foot facility will allow Sugar Land, Texas-based QuVa Pharma to expand its services to hospitals in the eastern half of the U.S.
The company currently owns two FDA-approved manufacturing facilities in Texas.
QuVa Pharma plans to hire more than 100 employees once the facility is operational in mid-2017.
Financial terms of the transaction were not disclosed.
More articles on supply chain:
FDA turns to banned factory to prevent cancer drug shortages
7 latest FDA approvals
Supply chain tip of the week: Don't underestimate the power of tidbits and newsletters